Researchers at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and Harvard’s School of Engineering and ...
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
Ultra-rare diseases often lack patient populations large enough to support randomized controlled trials. The question is not ...
The next generation of glucagonlike peptide 1 (GLP-1) weight-loss drugs has taken another step forward to U.S. Food and Drug Administration approval. In new clinical trial results from the ...
A new study shows how ERA combines large language models with tree search to rapidly build expert-level research software, outperforming leading benchmarks in tasks from single-cell genomics to ...
The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several ...
New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ ...
The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...
Hosted on MSN
3 different viruses keeping Georgia-based CDC busy
ATLANTA, Ga. — The Atlanta-based Centers for Disease Control and Prevention has its hands full tracking three distinct illnesses: Ebola, hantavirus and measles. More measles cases have been confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results